Search hospitals > Illinois > Kewanee

Illinois CancerCare-Kewanee Clinic

Claim this profile
Kewanee, Illinois 61443
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
376 reported clinical trials
2 medical researchers
Photo of Illinois CancerCare-Kewanee Clinic in KewaneePhoto of Illinois CancerCare-Kewanee Clinic in KewaneePhoto of Illinois CancerCare-Kewanee Clinic in Kewanee

Summary

Illinois CancerCare-Kewanee Clinic is a medical facility located in Kewanee, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Illinois CancerCare-Kewanee Clinic is involved with conducting 376 clinical trials across 470 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.

Area of expertise

1Cancer
Global Leader
Illinois CancerCare-Kewanee Clinic has run 140 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Illinois CancerCare-Kewanee Clinic has run 63 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Illinois CancerCare-Kewanee Clinic

Breast Cancer
Prostate Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Esophageal Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Bladder Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Illinois CancerCare-Kewanee Clinic?
Illinois CancerCare-Kewanee Clinic is a medical facility located in Kewanee, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Illinois CancerCare-Kewanee Clinic is involved with conducting 376 clinical trials across 470 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.
Where is Illinois CancerCare-Kewanee Clinic located?
**Illinois CancerCare-Kewanee Clinic** - **Address:** 1051 W South St, Kewanee, IL 61443 - **Location:** Approximately 1 mile west of downtown Kewanee, near the intersection of West South Street and Tenney Street.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Illinois CancerCare-Kewanee Clinic, please call (309) 243-3500 or toll-free at (866) 662-6564.
What insurance does Illinois CancerCare-Kewanee Clinic accept?
The Illinois CancerCare-Kewanee Clinic accepts most prescription insurance plans, including Medicare and Medicaid, and offers delivery options for prescriptions. They have a dedicated team focused on making medication affordable for patients. The clinic is affiliated with OSF Saint Luke's Medical Center, which accepts a variety of commercial and government health insurance plans. Patients should verify their insurance coverage and bring their insurance identification cards on their first visit.
What awards or recognition has Illinois CancerCare-Kewanee Clinic received?
Illinois CancerCare-Kewanee Clinic, situated in Kewanee, Illinois, specializes in treating cancer and blood diseases as part of the larger Illinois CancerCare practice. It is distinguished by its dedication to clinical research, maintaining around 100 open clinical cancer research trials at any given time. The clinic has earned recognition from the Quality Oncology Practice Initiative (QOPI®) Certification Program for meeting the highest national standards for quality cancer care and is a proud member of Heartland NCORP, leading the nation in cancer research enrollment.